共 50 条
- [31] COST-EFFECTIVENESS OF HA-1A MONOCLONAL-ANTIBODY FOR GRAM-NEGATIVE SEPSIS - ECONOMIC-ASSESSMENT OF A NEW THERAPEUTIC AGENT JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (24): : 3466 - 3471
- [32] EVALUATION OF A HUMAN MONOCLONAL-ANTIBODY TO LIPID-A EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 1986, 6 (03): : 139 - 141
- [34] EFFECTIVENESS OF A HUMAN MONOCLONAL ANTIENDOTOXIN ANTIBODY (HA-1A) IN GRAM-NEGATIVE SEPSIS - RELATIONSHIP TO ENDOTOXIN AND CYTOKINE LEVELS JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06): : 1367 - 1374
- [36] CHARACTERIZATION OF HA-1A HUMAN MONOCLONAL IGM ANTIBODY PRODUCED AT DIFFERENT PHASES OF LARGE-SCALE PERFUSION CELL-CULTURE FASEB JOURNAL, 1991, 5 (04): : A466 - A466
- [37] PREVENTION OF DEATH FROM GRAM-NEGATIVE BACTEREMIA AND SEPSIS BY HA-1A, A HUMAN MONOCLONAL-ANTIBODY SPECIFIC FOR LIPID-A OF ENDOTOXIN - RESULTS OF PHASE-III TRIAL CLINICAL RESEARCH, 1990, 38 (02): : A304 - A304
- [38] TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SEPTIC SHOCK WITH HA-1A HUMAN MONOCLONAL-ANTIBODY AGAINST ENDOTOXIN - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (07): : 429 - 436
- [39] E5 MONOCLONAL IMMUNOGLOBULIN-M ANTIBODY FOR THE TREATMENT OF GRAM-NEGATIVE SEPSIS DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (7-8): : 784 - 790